These results, together with a prior report showing that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 support the strategy of targeting ACKR3 as a singular solution to modulate the opioid program, which could open new therapeutic avenues for opioid-associated disorders. Importantly, these receptors ended up uncovered https://cordellx271moq2.wikistatement.com/user